- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Hi-Tech Pharmacal Co Inc
+ Add to WatchlistHITK:US
32.2700 USD 0.8300 2.64%As of 20:10:00 ET on 05/17/2013.
Snapshot for Hi-Tech Pharmacal Co Inc (HITK)
| Open: | 31.6400 | Day's Range: | 31.5900 - 32.4400 | Volume: | 47,683 |
|---|---|---|---|---|---|
| Previous Close: | 31.4400 | 52wk Range: | 26.1979 - 38.1700 | 1-Yr Rtn: | +13.85% |
Key Statistics for HITK
| Current P/E Ratio (ttm) | 15.0794 |
|---|---|
| Estimated P/E(04/2013) | 14.8368 |
| Relative P/E vs. SPX | 0.9242 |
| Earnings Per Share (USD) (ttm) | 2.1400 |
| Est. EPS (USD) (04/2013) | 2.1750 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 437.94 |
| Shares Outstanding (M) | 13.57 |
| 30 Day Average Volume | 49,486 |
| Price/Book (mrq) | 1.7612 |
| Price/Sale (ttm) | 1.8106 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend (USD) | 1.5000 |
| Last Dividend | 12/11/2012 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/10/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for HITK
Company Profile & Key Executives for HITK
Hi-Tech Pharmacal Co., Inc. manufactures prescription and over-the-counter generic and branded pharmaceuticals in liquid and semi-solid dosage forms. The Company also manufactures sterile ophthalmic, otic, and inhalation products and provides sterile manufacturing contract services. Hi-Tech markets its own products under names such as H-T, Rx Choice, DiabetiDerm, and Steri-Optics.
| David S SeltzerChairman/Pres/CEO/Treasurer | Reuben SeltzerVice Chairman |
| Kamel EgbariaExec VP/Chief Scientific Ofcr | William J PetersVP/CFO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
HITK News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page